Acute Coronary Syndrome Clinical Trials

Find Acute Coronary Syndrome Clinical Trials Near You

Digital Cognitive Behavioral Therapy for Cardiac Anxiety Following Acute Coronary Syndrome: a Randomized Controlled Trial Comparing CBT to a Digital Lifestyle Intervention

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The aim of this study is to evaluate if an online Cognitive Behavioral Therapy (CBT) protocol customized for patients following Acute Coronary Syndrome (ACS), reduce cardiac anxiety, enhance Quality of Life (QoL), and promote increased physical activity while controlling for caregiver attention, utilizing an active control group receiving internet-based cardiac lifestyle intervention.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• ACS ≥ 6 months before assessment (type 1 MI STEMI/NSTEMI or unstable angina \[UA\])

• Age 18 and older

• Clinically significant cardiac anxiety that leads to distress and/or interferes with daily life (Cardiac Anxiety Questionnaire; CAQ: ≥18

• Able to read and write in Swedish

Locations
Other Locations
Sweden
Karolinska University Hospital
RECRUITING
Stockholm
Contact Information
Primary
Josefin Särnholm, Lic psychologist, PhD
josefin.sarnholm@ki.se
+ 46 852483258
Time Frame
Start Date: 2024-03-07
Estimated Completion Date: 2027-10-31
Participants
Target number of participants: 176
Treatments
Experimental: Internet-based Cognitive Behavioral Therapy (Internet-CBT)
Internet-CBT following ACS is exposure-based, centering on exposure to cardiac related symptoms and situations. The CBT is therapist-guided and lasts for 8 weeks.
Active_comparator: Internet-based Cardiac Lifestyle intervention (Internet-CL)
Internet-CL is based on strategies for behavioral change and guidelines on health promoting lifestyle modifications following ACS. The Internet-CL is therapist-guided and lasts for 8 weeks.
Related Therapeutic Areas
Sponsors
Collaborators: Karolinska University Hospital
Leads: Karolinska Institutet

This content was sourced from clinicaltrials.gov